Naltrexone and Propranolol Combined With Immunotherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Naltrexone and Propranolol Combined With Immunotherapy — Stella

Recruiting

Back to Advanced Melanoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Key details

Phase

Early testing

Sponsor

Sarah Weiss

Enrollment target

~12 participants

Started

September 2023

Primary completion

September 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov